| Application no. and date | 15813578.0 (espacenet) (Federated) (European Patent Register), 20151210 | | Patent/reg. no. and date | DK/EP 3233054, 20210630 | | Publication date | 20171025 | | Priority no. and date | US 201462093060 P, 20141217, US 201562250633 P, 20151104 | | EP pub. no. and date |
EP 3233054 20171025 | | Effective date | | | Applicant/owner | Pfizer Inc., 66 Hudson Boulevard East
New York, NY 10001-2192, US | | Applicant ref. no. | V345974DK00 | | Inventor | BACK, Kevin Richard, Pfizer Limited
Ramsgate Road
Sandwich
Kent CT13 9NJ, GB,
CRAM, Michael, Pfizer Limited
Ramsgate Road
Sandwich
Kent CT13 9NJ, GB,
HARPER, Aidan James, Pfizer Limited
Ramsgate Road
Sandwich
Kent CT13 9NJ, GB,
HUANG, W. James, 8 Woodville Terrace
Somerville, New Jersey 08876, US,
LILLIS, Jonathan Richard, Ramsgate Road
Sandwich
Kent CT13 9NJ, GB,
LUKAS, Timothy Michael, Pfizer Limited
Ramsgate Road
Sandwich
Kent CT13 9NJ, GB,
LUTHRA, Sumit, 6 Cutter Lane
Westford, Massachusetts 01886, US | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 31/5377 (2006.01) , A61K 47/02 (2006.01) , A61K 47/12 (2006.01) , A61K 47/26 (2006.01) , A61K 9/00 (2006.01) , A61K 9/08 (2006.01) , A61K 9/19 (2006.01) , A61P 35/00 (2006.01) | | Title | Formuleringer af en PI3K/MTOR-hæmmer til intravenøs administration | | Int. application no. | IB2015059515 | | Int. publication no. | WO2016097949 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
